Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

BACKGROUND: To investigate the impact of pre-treatment lactate dehydrogenase (LDH) levels on the outcome of patients with metastatic colorectal cancer treated with first-line chemotherapy with or without the anti-VEGF monoclonal antibody, bevacizumab, in a phase III prospective multicentre randomize...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Passardi, Alessandro, Scarpi, Emanuela, Tamberi, Stefano, Cavanna, Luigi, Tassinari, Davide, Fontana, Annalisa, Pini, Sara, Bernardini, Ilaria, Accettura, Caterina, Ulivi, Paola, Frassineti, Giovanni Luca, Amadori, Dino
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526665/
https://ncbi.nlm.nih.gov/pubmed/26244985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0134732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados